Improving Retinal Disease Treatment with LabVIEW FPGA and Intelligent DAQ

    Jan. 7, 2010
    OptiMedica Corporation specializes in helping ophthalmologists treat retinal disease and have harnessed the power of graphical system design to develop PASCAL. PASCAL uses LabVIEW FPGA and intelligent DAQ to reduce treatment time as well as patient discomfort.
    Traditional methods of pan-retinal laser photocoagulation to treat retinal diseases caused by diabetes have changed little in the past 35 years. Laser photocoagulation involves the controlled destruction of the peripheral retina using targeted laser pulses. While this type of treatment has proven effective at reducing the chances of vision loss by as much as 50 percent, it can be very tedious to both patients and doctors. Ophthalmologists can deliver only one burn at a time, and treatment can require as many as 2,000 burns. A full course of treatment typically requires two to four sessions, each lasting 12 to 15 minutes.At OptiMedica, we specialize in designing medical devices that help ophthalmologists improve the way retinal disease is treated. We designed the PASCAL photocoagulator to be a fully integrated pattern scanning laser system that provides significantly improved performance for the physician administering the treatment, as well as an enhanced therapeutic experience for the patient. Read the full case study

    Companies in this Article

    Continued Reading

    Sponsored Recommendations

    SEW-EURODRIVE Introduces DR2C motor, IE5 Ultra-Premium Efficiency Motor
    Optimize food production with SEW-EURODRIVE’s hygienic, energy-efficient automation and drive solutions for precision, reliability, and sustainability.
    George Reed, with the help of Factory Technologies, was looking to further automate the processes at its quarries and make Ignition an organization-wide standard.

    Sponsored